These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 14620963)

  • 21. Percent free PSA as an additional measure in a prostate cancer screen.
    Miele ME
    Clin Lab Sci; 2001; 14(2):102-7. PubMed ID: 15625982
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The importance of patient preference in the decision to screen for prostate cancer. Prostate Patient Outcomes Research Team.
    Flood AB; Wennberg JE; Nease RF; Fowler FJ; Ding J; Hynes LM
    J Gen Intern Med; 1996 Jun; 11(6):342-9. PubMed ID: 8803740
    [TBL] [Abstract][Full Text] [Related]  

  • 23. All care, but whose responsibility? Community juries reason about expert and patient responsibilities in prostate-specific antigen screening for prostate cancer.
    Degeling C; Carter SM; Rychetnik L
    Health (London); 2016 Sep; 20(5):465-84. PubMed ID: 27491944
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Medical Maximizing-Minimizing Preferences Predict Responses to Information about Prostate-Specific Antigen Screening.
    Scherer LD; Kullgren JT; Caverly T; Scherer AM; Shaffer VA; Fagerlin A; Zikmund-Fisher BJ
    Med Decis Making; 2018 Aug; 38(6):708-718. PubMed ID: 29916784
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Promoting informed prostate cancer screening decision-making for African American men in a community-based setting.
    Wray RJ; Nicks SE; Adsul P; Elliot M; Enard K; Jupka K; Trainer AK; Hansen N; Shahid M; Wright-Jones R; Siddiqui S
    Cancer Causes Control; 2022 Apr; 33(4):503-514. PubMed ID: 35091864
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Does evidence-based information about screening for prostate cancer enhance consumer decision-making? A randomised controlled trial.
    Gattellari M; Ward JE
    J Med Screen; 2003; 10(1):27-39. PubMed ID: 12790313
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Does 'peer coaching' increase GP capacity to promote informed decision making about PSA screening? A cluster randomised trial.
    Gattellari M; Donnelly N; Taylor N; Meerkin M; Hirst G; Ward JE
    Fam Pract; 2005 Jun; 22(3):253-65. PubMed ID: 15824055
    [TBL] [Abstract][Full Text] [Related]  

  • 28. National trends in prostate cancer screening among older American men with limited 9-year life expectancies: evidence of an increased need for shared decision making.
    Drazer MW; Prasad SM; Huo D; Schonberg MA; Dale W; Szmulewitz RZ; Eggener SE
    Cancer; 2014 May; 120(10):1491-8. PubMed ID: 24523016
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Screening for prostate cancer in U.S. men ACPM position statement on preventive practice.
    Lim LS; Sherin K;
    Am J Prev Med; 2008 Feb; 34(2):164-70. PubMed ID: 18201648
    [TBL] [Abstract][Full Text] [Related]  

  • 30. US men discussing prostate-specific antigen tests with a physician.
    McFall SL
    Ann Fam Med; 2006; 4(5):433-6. PubMed ID: 17003144
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Do Men Receive Information Required for Shared Decision Making About PSA Testing? Results from a National Survey.
    Leyva B; Persoskie A; Ottenbacher A; Hamilton JG; Allen JD; Kobrin SC; Taplin SH
    J Cancer Educ; 2016 Dec; 31(4):693-701. PubMed ID: 26498649
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Informed decision making and prostate specific antigen (PSA) testing for prostate cancer: a randomised controlled trial exploring the impact of a brief patient decision aid on men's knowledge, attitudes and intention to be tested.
    Watson E; Hewitson P; Brett J; Bukach C; Evans R; Edwards A; Elwyn G; Cargill A; Austoker J
    Patient Educ Couns; 2006 Nov; 63(3):367-79. PubMed ID: 16875796
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recent Patterns in Shared Decision Making for Prostate-Specific Antigen Testing in the United States.
    Fedewa SA; Gansler T; Smith R; Sauer AG; Wender R; Brawley OW; Jemal A
    Ann Fam Med; 2018 Mar; 16(2):139-144. PubMed ID: 29531105
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Factors influencing primary care physicians' decision to order prostate-specific antigen (PSA) test for men without prostate cancer.
    Hayat Roshanai A; Nordin K; Berglund G
    Acta Oncol; 2013 Nov; 52(8):1602-8. PubMed ID: 23421929
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Screening for prostate cancer. The challenge of promoting informed decision making in the absence of definitive evidence of effectiveness.
    Burack RC; Wood DP
    Med Clin North Am; 1999 Nov; 83(6):1423-42, vi. PubMed ID: 10584601
    [TBL] [Abstract][Full Text] [Related]  

  • 36. African American Women's Involvement in Promoting Informed Decision-Making for Prostate Cancer Screening Among Their Partners/Spouses.
    Allen JD; Akinyemi IC; Reich A; Fleary S; Tendulkar S; Lamour N
    Am J Mens Health; 2018 Jul; 12(4):884-893. PubMed ID: 29298558
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prostate cancer screening behavior in men from seven ethnic groups: the fear factor.
    Consedine NS; Morgenstern AH; Kudadjie-Gyamfi E; Magai C; Neugut AI
    Cancer Epidemiol Biomarkers Prev; 2006 Feb; 15(2):228-37. PubMed ID: 16492909
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The evaluation of two methods to facilitate shared decision making for men considering the prostate-specific antigen test.
    Frosch DL; Kaplan RM; Felitti V
    J Gen Intern Med; 2001 Jun; 16(6):391-8. PubMed ID: 11422636
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Factors influencing use of the prostate-specific antigen screening test in primary care.
    Moran WP; Cohen SJ; Preisser JS; Wofford JL; Shelton BJ; McClatchey MW
    Am J Manag Care; 2000 Mar; 6(3):315-24. PubMed ID: 10977432
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Prostate cancer screening using prostate-specific antigen: The views of general and laboratory physicians].
    Giménez N; Filella X; Gavagnach M; Allué JA; Pedrazas D; Ferrer F;
    Semergen; 2018 Sep; 44(6):409-419. PubMed ID: 29574008
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.